Investors must take note of Apellis Pharmaceuticals Inc’s (APLS) performance last week, which was -5.98%.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) kicked off on Tuesday, up 2.27% from the previous trading day, before settling in for the closing price of $47.64.